Global Tissue Diagnostics Market

Global Tissue Diagnostics Market Size, Share, Growth Analysis, By Technology(ISH, Digital Pathology), By Disease(Breast Cancer, Prostate Cancer), By Region(North America, Europe) - Industry Forecast 2024-2031


Report ID: SQMIG35H2161 | Region: Global | Published Date: April, 2024
Pages: 242 | Tables: 94 | Figures: 76

Global Tissue Diagnostics Market Insights

Tissue Diagnostics Market size was valued at USD 4.97 billion in 2019 and is poised to grow from USD 5.3 billion in 2023 to USD 9.42 billion by 2031, growing at a CAGR of 6.6% in the forecast period (2024-2031).

With an increasing number of cancer cases across the globe, the tissue diagnostics market has witnessed a high demand along with lucrative growth opportunities in the near future. In addition, rising adoption of automated tissue-based diagnostic systems by various research institutes enables them to perform a faster and advanced diagnosis of tumors. For instance, in September 2019, West Clinic Center partnered with F. Hoffmann-La Roche Ltd. To improve caring system of patient by using Roche’s BenchMark ULTRA Automated Advanced Staining System.

According to a report of Worldwide Office for Exploration on Cancer (IARC), by 2031, the worldwide weight is relied upon to treatment to 21.7 million new disease cases and about 13 million new cancer cases growth, because of the development and maturing of the population, aside from different components such as poor diet, smoking, and fewer childbirths. The rapid increase in the number of diseases is expected to boost the growth of the global tissue diagnostics market.

Furthermore, a rise in the focus of major market players to develop advanced tissue-diagnostic based and companion diagnostic tests is likely to be the major driving factor of the global tissue diagnostics market during the forecast period. For instance, in May 2022, Leica Biosystems launched its BOND-PRIME, an advanced staining solution for the expansion of diagnostic productivity in laboratories. This new system enables lab technician to load any slides in any combination, and with any reagent, at any time.

US Tissue Diagnostics Market is poised to grow at a sustainable CAGR for the next forecast year.

To get more reports on the above market click here to Buy The Report

Global Tissue Diagnostics Market Segmental Analysis

Global tissue diagnostics market is segmented on the basis of technology, disease, and region. By technology, the Tissue Diagnostics Market is sub-segmented into ISH, digital pathology, special staining, and IHC. By disease, the Tissue Diagnostics Market is categorized into breast cancer, prostate cancer, lymphoma, and NSCLC. By region, the Tissue Diagnostics Market is segmented into North America, Europe, Asia Pacific, Latin America, and MEA.

Tissue Diagnostics Market Analysis by Technology

By technology, the IHC segment held the largest market share in 2021 and is expected to maintain its dominance throughout the forecast period. IHC is largely used in the clinical research and advancement and development of cancer diagnostics. Most normal histology tests are not capable to decide the beginning of a tumor, yet IHC has several tests that can be assisted to figure out where a tumor has come from.

Moreover, the digital pathology segment is expected to grow at fastest CAGR during the forecast period owing to high usage in image information system by using computer technology. Increase in the appropriation rate of whole slide imaging (WSI) among the pathologists, is one of the major factors driving the market growth.

Tissue Diagnostics Market Analysis by Disease

By disease, the breast cancer segment held the largest market share in 2021, and it is set to continue over the forecast period, owing to an increase in the number of breast cancer patients across the globe. In addition, a few explorations drives have combined with the help of public authorities and private centers, is further expected to drive the development of advanced products for the diagnosis of breast cancer. In 2021, according to American Disease Society, it was assessed that about 30% of the recently analysed cancer cases among ladies were breast cancers.

To get detailed analysis on other segments, Request For Free Sample Report

Global Tissue Diagnostics Market Regional Insights

Globally, North America held the biggest market share in 2021, and is expected to maintain its dominance throughout the forecast period. Due to the good healthcare system, presence of qualified professionals, strong presence of major manufacturers, advanced procedures, and high adoption of Mi surgical systems in the region. Moreover, continuously increasing investment in the R&D to create new and more advance products is likely to have a positive impact on the market in the region. According to National Cancer Institutes, the number of cancer cases in the United States was around 17.2 million in 2021, and it is expected to reach 20.3 million by 2026.

Furthermore, Asia Pacific is expected to grow at a significant growth rate during the forecast period due to the rising awareness among people regarding health issues and introduction to the latest technologies available in the market. Which helps in the growth of infrastructure of the hospitals and new healthcare facilities in the region as well. According to our findings, more than 2.26 million people are living with cancer in the India with almost 7 lakh people dying due to the disease. Furthermore, favourable R&D initiatives and government funding towards development and launch of advanced diagnostics centres would complement the regional growth.

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Global Tissue Diagnostics Market Dynamics

Tissue Diagnostics Market Drivers

  • Rising prevalence of cancer at a high rate is a major driving factor of the market during the forecast period. The incidence of cancer is the highest in developed regions; however, cancer mortality is relatively higher in developing regions due to the various factors such as lack of access to advanced treatment facilities and the late detection of cancer in several patients. According to the WHO, approximately 70% of deaths due to cancer were reported in low-income and middle-income countries in the year 2020.
  • The escalating healthcare expenditures through governments as well as private sector have become a primary driver of the global tissue diagnostics market. As the government bodies of several countries are focusing towards building a robust healthcare infrastructure, the number of hospitals and diagnostic laboratories is increasing largely. Furthermore, due to the increase in the per capita income of people, they are spending higher on their health and body.

Tissue Diagnostics Market Restraint

  • Lack of awareness among people about tissue diagnostics in rising economies, combined with low extra income, are major factors expected to hamper the market growth during the forecast period.
  • Shortage of trained staff in the laboratories across the world is another major factor restraining the market growth in the coming years. For instance, in the UK only 3% of diagnostics laboratories has sufficient staff to deliver their diagnostic and routine tasks such as reporting of workload.

Request Free Customization of this report to help us to meet your business objectives.

Global Tissue Diagnostics Market Competitive Landscape

The global tissue diagnostics market is fairly competitive with the presence of few large players across the globe such as Abbott Laboratories, Danaher Corporation, Agilent Technologies. The companies are investing significant amount in the research & development sector to expand their product portfolio to consolidate their position in the market. In addition, partnerships, acquisitions, collaboration are few other strategies opting by several market players.

Top Players in the Global Tissue Diagnostics Market

  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Abbott Laboratories
  • Merck KGaA
  • Becton, Dickinson and Company
  • Qiagen N.V.
  • Biogenex Laboratories, Inc.
  • Sakura Finetek USA, Inc.
  • Bio SB
  • Abcam plc
  • Cell Signaling Technology, Inc.
  • Bio-Rad Laboratories, Inc.
  • Enzo Biochem, Inc.
  • Leica Biosystems Nussloch GmbH
  • Siemens Healthcare GmbH
  • Ventana Medical Systems, Inc.
  • Agendia, Inc.
  • Myriad Genetics, Inc.

Tissue Diagnostics Market Recent Developments

  • In May 2021, Discovery Life Sciences, a global biospecimen, and biomarker-specialists company has announced to acquire Targos Molecular Pathology GmbH, A Germany based molecular pathology laboratory. This acquisition is mainly aimed towards expansion of Discovery Life Science services, making it a global provider for biomarker development, and clinical trial support.
  • In May 2021, Roche Diagnostics, a sub-division of the Hoffmann-La Roche Ltd. Announced its partnership with Canadian Blood Services, a Canadian based non-profit organization to expand the study immune response to SARS-CoV-2.

Global Tissue Diagnostics Key Market Trends

  • Shift in paradigm from conventional types of pathology method towards digital pathology is one of the major emerging trends likely to shape global tissue diagnostics market during the forecast period. Key companies such as Abbott Laboratories and F. Hoffmann are highly focusing on the development of diagnostic tests that aim to provide critical information. For example, FISH tests play a very important role in diagnosis of solid neoplasms and biomarker hematologic. Also, it is being implemented in the field of personalized medicine.
  • Rising use of advanced technologies, as well as the massive amount of research being done to understand this issue with more ease and more effectively, has been a major contributor to the growth in breast cancer diagnoses. The industry is also growing due to the implementation of sophisticated technology for diagnosis and research.

Global Tissue Diagnostics Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.

According to our analysis, global tissue diagnostics market is expected to grow at a significant CAGR during the forecast period owing to increasing awareness among people, increasing expenditure on research & development, adoption of diagnosis systems across the globe, and partnerships and collaboration among key players of the market. In addition, the increasing expenditure on healthcare infrastructure by government bodies as well as private players in the developing nations such as India, China, Indonesia, and South Africa are expected to fuel the demand and growth of the market over the forecast period.

Report Metric Details
Market size value in 2023 USD 4.97 billion
Market size value in 2031 USD 9.42 billion
Growth Rate 6.6%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Technology
    • ISH, Digital Pathology, Special Staining, IHC
  • Disease
    • Breast Cancer, Prostate Cancer, Lymphoma, NSCLC
  • Region
    • North America, Europe, Asia Pacific, Latin America, MEA
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Abbott Laboratories
  • Merck KGaA
  • Becton, Dickinson and Company
  • Qiagen N.V.
  • Biogenex Laboratories, Inc.
  • Sakura Finetek USA, Inc.
  • Bio SB
  • Abcam plc
  • Cell Signaling Technology, Inc.
  • Bio-Rad Laboratories, Inc.
  • Enzo Biochem, Inc.
  • Leica Biosystems Nussloch GmbH
  • Siemens Healthcare GmbH
  • Ventana Medical Systems, Inc.
  • Agendia, Inc.
  • Myriad Genetics, Inc.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

Historical Year 2019

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Global Tissue Diagnostics Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Tissue Diagnostics Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Global Tissue Diagnostics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Tissue Diagnostics Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Tissue Diagnostics Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Global Tissue Diagnostics Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Tissue Diagnostics Market size was valued at USD 4.97 billion in 2019 and is poised to grow from USD 5.3 billion in 2023 to USD 9.42 billion by 2031, growing at a CAGR of 6.6% in the forecast period (2024-2031).

The global tissue diagnostics market is fairly competitive with the presence of few large players across the globe such as Abbott Laboratories, Danaher Corporation, Agilent Technologies. The companies are investing significant amount in the research & development sector to expand their product portfolio to consolidate their position in the market. In addition, partnerships, acquisitions, collaboration are few other strategies opting by several market players. 'F. Hoffmann-La Roche Ltd.', 'Danaher Corporation', 'Thermo Fisher Scientific Inc.', 'Agilent Technologies, Inc.', 'Abbott Laboratories', 'Merck KGaA', 'Becton, Dickinson and Company', 'Qiagen N.V.', 'Biogenex Laboratories, Inc.', 'Sakura Finetek USA, Inc.', 'Bio SB', 'Abcam plc', 'Cell Signaling Technology, Inc.', 'Bio-Rad Laboratories, Inc.', 'Enzo Biochem, Inc.', 'Leica Biosystems Nussloch GmbH', 'Siemens Healthcare GmbH', 'Ventana Medical Systems, Inc.', 'Agendia, Inc.', 'Myriad Genetics, Inc.'

Rising prevalence of cancer at a high rate is a major driving factor of the market during the forecast period. The incidence of cancer is the highest in developed regions; however, cancer mortality is relatively higher in developing regions due to the various factors such as lack of access to advanced treatment facilities and the late detection of cancer in several patients. According to the WHO, approximately 70% of deaths due to cancer were reported in low-income and middle-income countries in the year 2020.

Shift in paradigm from conventional types of pathology method towards digital pathology is one of the major emerging trends likely to shape global tissue diagnostics market during the forecast period. Key companies such as Abbott Laboratories and F. Hoffmann are highly focusing on the development of diagnostic tests that aim to provide critical information. For example, FISH tests play a very important role in diagnosis of solid neoplasms and biomarker hematologic. Also, it is being implemented in the field of personalized medicine.

Globally, North America held the biggest market share in 2021, and is expected to maintain its dominance throughout the forecast period. Due to the good healthcare system, presence of qualified professionals, strong presence of major manufacturers, advanced procedures, and high adoption of Mi surgical systems in the region. Moreover, continuously increasing investment in the R&D to create new and more advance products is likely to have a positive impact on the market in the region. According to National Cancer Institutes, the number of cancer cases in the United States was around 17.2 million in 2021, and it is expected to reach 20.3 million by 2026.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Tissue Diagnostics Market

Product ID: SQMIG35H2161

$5,300
BUY NOW GET FREE SAMPLE